Radiation therapy is often seen as a powerful weapon against cancer. But a surprising new study from the University of ...

SANTIAGO DE COMPOSTELA, Spain & SHANGHAI, China I June 17, 2025 I SunRock Biopharma and Escugen have joined forces in a strategic partnership to ...

What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Monday showed that Echelard sold 10,000 shares of TG Therapeutics. The total transaction amounted to $369,400. In the ...

Scientists uncover surprising immune response that helps tumors grow, revealing new strategies to improve treatment ...

Following a successful launch of Phase 2 clinical trials in March, HanchorBio Inc., a pioneer of immunotherapy biologics, is announcing interim data for a concurrent Phase 1b dose-escalation trial ...

Immunotherapy has revolutionized cancer treatment by mobilizing the immune system to attack tumor cells. Major advances, such as immune checkpoint inhibitors (notably against the PD-1 protein), have ...

TAINAN, Taiwan I June 12, 2025 I Merry Life Biomedical Company announces the launch of its global Phase II clinical trial for TML-6, a novel oral small ...

Colorectal cancer remains one of the leading causes of cancer-related mortality worldwide. Recent advancements in ...

Obesity is a major public health concern, and effective treatments are still elusive. AMP-activated protein kinase (AMPK) is a crucial regulator of energy homeostasis and has been proposed as a target ...

Dietmar Berger, M.D., Ph.D., joined Gilead Sciences as chief medical of | Dietmar Berger became Gilead Sciences’ new chief ...

The Niskayuna Community Foundation will be marking its 25th anniversary with a day of service on Saturday that will see more ...

BYON4228 is a potential best-in-class novel mAb that targets and blocks the CD47-SIRPa axis, responsible for tumours’ ability to escape from recognition and destruction by the immune system. By ...